
Big pharma reporting season was muted, with the quarterly results and guidance coming in mixed.
Merck & Co Inc (NYSE:MRK) shares pulled back despite the company reporting this week above-consensus results, with the negative reaction reflecting investors concerns over the sustainability of its oral COVID-19 pill revenues. Roche Holding AG (OTC:RHHBY) also pulled back as the Swiss pharma giant flagged slowing COVID testing revenues.